Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
Identifieur interne : 003D66 ( Main/Exploration ); précédent : 003D65; suivant : 003D67Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
Auteurs : Sandra C. Hayes [Australie] ; Karin Johansson ; Nicole L. Stout ; Robert Prosnitz ; Jane M. Armer ; Sheryl Gabram ; Kathryn H. SchmitzSource :
- Cancer [ 1097-0142 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Amplitude articulaire (physiologie), Complications postopératoires (), Complications postopératoires (épidémiologie), Congrès comme sujet, Douleur (rééducation et réadaptation), Douleur (épidémiologie), Douleur (étiologie), Facteurs temps, Faiblesse musculaire (rééducation et réadaptation), Faiblesse musculaire (épidémiologie), Faiblesse musculaire (étiologie), Femelle, Humains, Incidence, Indice de gravité médicale, Lymphoedème (rééducation et réadaptation), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Mastectomie (), Mastectomie (effets indésirables), Mastectomie (rééducation et réadaptation), Membre supérieur (physiopathologie), Modèles d'organisation, Prestation intégrée de soins de santé (organisation et administration), Prévention primaire (), Qualité de vie, Société américaine du cancer, Sujet âgé, Tumeurs du sein (), Tumeurs du sein (mortalité), Tumeurs du sein (rééducation et réadaptation), Études de suivi, Études longitudinales, Études prospectives, Évaluation de l'incapacité.
- MESH :
- effets indésirables : Mastectomie.
- mortalité : Tumeurs du sein.
- organisation et administration : Prestation intégrée de soins de santé.
- physiologie : Amplitude articulaire.
- physiopathologie : Membre supérieur.
- rééducation et réadaptation : Douleur, Faiblesse musculaire, Lymphoedème, Mastectomie, Tumeurs du sein.
- épidémiologie : Complications postopératoires, Douleur, Faiblesse musculaire, Lymphoedème.
- étiologie : Douleur, Faiblesse musculaire, Lymphoedème.
- Adulte, Adulte d'âge moyen, Complications postopératoires, Congrès comme sujet, Facteurs temps, Femelle, Humains, Incidence, Indice de gravité médicale, Mastectomie, Modèles d'organisation, Prévention primaire, Qualité de vie, Société américaine du cancer, Sujet âgé, Tumeurs du sein, Études de suivi, Études longitudinales, Études prospectives, Évaluation de l'incapacité.
English descriptors
- KwdEn :
- Adult, Aged, American Cancer Society, Breast Neoplasms (mortality), Breast Neoplasms (rehabilitation), Breast Neoplasms (surgery), Congresses as Topic, Delivery of Health Care, Integrated (organization & administration), Disability Evaluation, Female, Follow-Up Studies, Humans, Incidence, Longitudinal Studies, Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (rehabilitation), Mastectomy (adverse effects), Mastectomy (methods), Mastectomy (rehabilitation), Middle Aged, Models, Organizational, Muscle Weakness (epidemiology), Muscle Weakness (etiology), Muscle Weakness (rehabilitation), Pain (epidemiology), Pain (etiology), Pain (rehabilitation), Postoperative Complications (epidemiology), Postoperative Complications (prevention & control), Primary Prevention (methods), Prospective Studies, Quality of Life, Range of Motion, Articular (physiology), Severity of Illness Index, Time Factors, Upper Extremity (physiopathology).
- MESH :
- adverse effects : Mastectomy.
- epidemiology : Lymphedema, Muscle Weakness, Pain, Postoperative Complications.
- etiology : Lymphedema, Muscle Weakness, Pain.
- methods : Mastectomy, Primary Prevention.
- mortality : Breast Neoplasms.
- organization & administration : Delivery of Health Care, Integrated.
- physiology : Range of Motion, Articular.
- physiopathology : Upper Extremity.
- prevention & control : Postoperative Complications.
- rehabilitation : Breast Neoplasms, Lymphedema, Mastectomy, Muscle Weakness, Pain.
- surgery : Breast Neoplasms.
- Adult, Aged, American Cancer Society, Congresses as Topic, Disability Evaluation, Female, Follow-Up Studies, Humans, Incidence, Longitudinal Studies, Middle Aged, Models, Organizational, Prospective Studies, Quality of Life, Severity of Illness Index, Time Factors.
Abstract
The purpose of this paper is to review the incidence of upper-body morbidity (arm and breast symptoms, impairments, and lymphedema), methods for diagnosis, and prevention and treatment strategies. It was also the purpose to highlight the evidence base for integration of prospective surveillance for upper-body morbidity within standard clinical care of women with breast cancer. Between 10% and 64% of women report upper-body symptoms between 6 months and 3 years after breast cancer, and approximately 20% develop lymphedema. Symptoms remain common into longer-term survivorship, and although lymphedema may be transient for some, those who present with mild lymphedema are at increased risk of developing moderate to severe lymphedema. The etiology of morbidity seems to be multifactorial, with the most consistent risk factors being those associated with extent of treatment. However, known risk factors cannot reliably distinguish between those who will and will not develop upper-body morbidity. Upper-body morbidity may be treatable with physical therapy. There is also evidence in support of integrating regular surveillance for upper-body morbidity into the routine care provided to women with breast cancer, with early diagnosis potentially contributing to more effective management and prevention of progression of these conditions.
DOI: 10.1002/cncr.27467
PubMed: 22488698
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002171
- to stream PubMed, to step Curation: 002171
- to stream PubMed, to step Checkpoint: 002171
- to stream Ncbi, to step Merge: 004C54
- to stream Ncbi, to step Curation: 004C54
- to stream Ncbi, to step Checkpoint: 004C54
- to stream Main, to step Merge: 003D78
- to stream Main, to step Curation: 003D66
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.</title>
<author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
</author>
<author><name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</author>
<author><name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author><name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22488698</idno>
<idno type="pmid">22488698</idno>
<idno type="doi">10.1002/cncr.27467</idno>
<idno type="wicri:Area/PubMed/Corpus">002171</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002171</idno>
<idno type="wicri:Area/PubMed/Curation">002171</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002171</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002171</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002171</idno>
<idno type="wicri:Area/Ncbi/Merge">004C54</idno>
<idno type="wicri:Area/Ncbi/Curation">004C54</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004C54</idno>
<idno type="wicri:Area/Main/Merge">003D78</idno>
<idno type="wicri:Area/Main/Curation">003D66</idno>
<idno type="wicri:Area/Main/Exploration">003D66</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.</title>
<author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
<affiliation wicri:level="1"><nlm:affiliation>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane, Australia. sc.hayes@qut.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Queensland University of Technology, Institute of Health and Biomedical Innovation, School of Public Health, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
</author>
<author><name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</author>
<author><name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
</author>
<author><name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
</author>
</analytic>
<series><title level="j">Cancer</title>
<idno type="eISSN">1097-0142</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>American Cancer Society</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (rehabilitation)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Congresses as Topic</term>
<term>Delivery of Health Care, Integrated (organization & administration)</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (rehabilitation)</term>
<term>Mastectomy (adverse effects)</term>
<term>Mastectomy (methods)</term>
<term>Mastectomy (rehabilitation)</term>
<term>Middle Aged</term>
<term>Models, Organizational</term>
<term>Muscle Weakness (epidemiology)</term>
<term>Muscle Weakness (etiology)</term>
<term>Muscle Weakness (rehabilitation)</term>
<term>Pain (epidemiology)</term>
<term>Pain (etiology)</term>
<term>Pain (rehabilitation)</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Primary Prevention (methods)</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Range of Motion, Articular (physiology)</term>
<term>Severity of Illness Index</term>
<term>Time Factors</term>
<term>Upper Extremity (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Amplitude articulaire (physiologie)</term>
<term>Complications postopératoires ()</term>
<term>Complications postopératoires (épidémiologie)</term>
<term>Congrès comme sujet</term>
<term>Douleur (rééducation et réadaptation)</term>
<term>Douleur (épidémiologie)</term>
<term>Douleur (étiologie)</term>
<term>Facteurs temps</term>
<term>Faiblesse musculaire (rééducation et réadaptation)</term>
<term>Faiblesse musculaire (épidémiologie)</term>
<term>Faiblesse musculaire (étiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité médicale</term>
<term>Lymphoedème (rééducation et réadaptation)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie ()</term>
<term>Mastectomie (effets indésirables)</term>
<term>Mastectomie (rééducation et réadaptation)</term>
<term>Membre supérieur (physiopathologie)</term>
<term>Modèles d'organisation</term>
<term>Prestation intégrée de soins de santé (organisation et administration)</term>
<term>Prévention primaire ()</term>
<term>Qualité de vie</term>
<term>Société américaine du cancer</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (rééducation et réadaptation)</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
<term>Évaluation de l'incapacité</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Mastectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
<term>Muscle Weakness</term>
<term>Pain</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
<term>Muscle Weakness</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mastectomy</term>
<term>Primary Prevention</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Prestation intégrée de soins de santé</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Delivery of Health Care, Integrated</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Amplitude articulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Range of Motion, Articular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Membre supérieur</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Upper Extremity</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
<term>Mastectomy</term>
<term>Muscle Weakness</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
<term>Mastectomie</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur</term>
<term>Faiblesse musculaire</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>American Cancer Society</term>
<term>Congresses as Topic</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Longitudinal Studies</term>
<term>Middle Aged</term>
<term>Models, Organizational</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Severity of Illness Index</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Complications postopératoires</term>
<term>Congrès comme sujet</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité médicale</term>
<term>Mastectomie</term>
<term>Modèles d'organisation</term>
<term>Prévention primaire</term>
<term>Qualité de vie</term>
<term>Société américaine du cancer</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
<term>Évaluation de l'incapacité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of this paper is to review the incidence of upper-body morbidity (arm and breast symptoms, impairments, and lymphedema), methods for diagnosis, and prevention and treatment strategies. It was also the purpose to highlight the evidence base for integration of prospective surveillance for upper-body morbidity within standard clinical care of women with breast cancer. Between 10% and 64% of women report upper-body symptoms between 6 months and 3 years after breast cancer, and approximately 20% develop lymphedema. Symptoms remain common into longer-term survivorship, and although lymphedema may be transient for some, those who present with mild lymphedema are at increased risk of developing moderate to severe lymphedema. The etiology of morbidity seems to be multifactorial, with the most consistent risk factors being those associated with extent of treatment. However, known risk factors cannot reliably distinguish between those who will and will not develop upper-body morbidity. Upper-body morbidity may be treatable with physical therapy. There is also evidence in support of integrating regular surveillance for upper-body morbidity into the routine care provided to women with breast cancer, with early diagnosis potentially contributing to more effective management and prevention of progression of these conditions.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<name sortKey="Gabram, Sheryl" sort="Gabram, Sheryl" uniqKey="Gabram S" first="Sheryl" last="Gabram">Sheryl Gabram</name>
<name sortKey="Johansson, Karin" sort="Johansson, Karin" uniqKey="Johansson K" first="Karin" last="Johansson">Karin Johansson</name>
<name sortKey="Prosnitz, Robert" sort="Prosnitz, Robert" uniqKey="Prosnitz R" first="Robert" last="Prosnitz">Robert Prosnitz</name>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
<name sortKey="Stout, Nicole L" sort="Stout, Nicole L" uniqKey="Stout N" first="Nicole L" last="Stout">Nicole L. Stout</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D66 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D66 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:22488698 |texte= Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22488698" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |